{
    "clinical_study": {
        "@rank": "67265", 
        "arm_group": {
            "arm_group_label": "Macular diseases", 
            "description": "ranibizumab, intravitreal injections, 0.5mg, monthly or less aflibercept,intravitreal injections, 2.0mg, monthly or less pegaptanib, intravitreal injections, 0.3mg, every 6-week pars plana vitrectomy, once verteporphin, iv, 6mg/\u33a1"
        }, 
        "brief_summary": {
            "textblock": "Recent clinical introduction of anti-vascular endothelial growth factor agents may change\n      the clinical course of macular diseases, including age-related macular degeneration (AMD),\n      polypoidal choroidal vasculopathy (PCV), retinal angiomatous proliferation (RAP), central\n      serous chorioretinopathy (CSC), myopic choroidal neovascularization (CNV), retinal vein\n      occlusion (RVO), diabetic macular edema (DME), and so forth.\n\n      Patients with such macular diseases are registered and and are followed up for 5 years with\n      appropriate treatment for each patient. By the analysis of the correlation between initial\n      examinations and final visual acuity, factors associated with good visual prognosis will be\n      elucidated."
        }, 
        "brief_title": "Cohort Study of the Clinical Course of Macular Diseases in Japanese", 
        "completion_date": {
            "#text": "March 2024", 
            "@type": "Anticipated"
        }, 
        "condition": "Macular Disease", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients who visit Department of Ophthalmology Kyoto University Hospital with macular\n             diseases.\n\n          -  Patients who are agreed with the participation of this study.\n\n        Exclusion Criteria:\n\n          -  None"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients who visit Department of Ophthalmology Kyoto University Hospital with macular\n        diseases."
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 22, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02081339", 
            "org_study_id": "E2038"
        }, 
        "intervention": {
            "arm_group_label": "Macular diseases", 
            "intervention_name": "ranibizumab, aflibercept, pegaptanib, verteporphin", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Verteporfin"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 6, 2014", 
        "location": {
            "contact": {
                "email": "misao@kuhp.kyoto-u.ac.jp", 
                "last_name": "Misao Ogaki", 
                "phone": "+81-75-751-3248"
            }, 
            "facility": {
                "address": {
                    "city": "Kyoto", 
                    "country": "Japan", 
                    "zip": "606-8507"
                }, 
                "name": "Kyoto University Graduate School of Medicine"
            }, 
            "investigator": {
                "last_name": "Akitaka Tsujikawa, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_groups": "1", 
        "official_title": "Cohort Study of the Clinical Course of Macular Diseases in Japanese Patients", 
        "other_outcome": {
            "measure": "The change in visual acuity in each macular diseases.", 
            "safety_issue": "No", 
            "time_frame": "Five years after the registration."
        }, 
        "overall_contact": {
            "email": "tujikawa@kuhp.kyoto-u.ac.jp", 
            "last_name": "Akitaka Tsujikawa, MD", 
            "phone": "+81-75-751-3260"
        }, 
        "overall_official": {
            "affiliation": "Kyoto University, Graduate School of Medicine", 
            "last_name": "Nagahisa Yoshimura, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Japan: Ministry of Health, Labor and Welfare", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2022", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Initial factors associated with visual prognosis in each macular disease", 
            "safety_issue": "No", 
            "time_frame": "Five years after the registration"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02081339"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Kyoto University, Graduate School of Medicine", 
            "investigator_full_name": "Nagahisa Yoshimura", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "The difference in the visual prognosis depending on the treatments in each macular diseases", 
            "safety_issue": "No", 
            "time_frame": "Five years after the registration"
        }, 
        "source": "Kyoto University, Graduate School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kyoto University, Graduate School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "5 Years", 
        "verification_date": "March 2014"
    }
}